Search Articles — Sudonull

Search Results

In this project

Microservices Communication Tools Kafka Feign

https://sudonull.com/microservices-communication-tools-kafka-feign

Breakdown of HTTP clients WebClient, Feign, WebSocket and Kafka for microservices. Reactivity, delivery guarantees, code examples. Choose a tool for load and tasks.

Bot Communication in Telegram: How to Set Up

https://sudonull.com/bot-communication-in-telegram-how-to-set-up

Telegram has allowed bots to communicate with each other via mentions and replies. Setup in BotFather, code review examples and integration with OpenClaw. Instructions for developers — read and implement in projects.

From other projects

Antidepressant mianserin extends life: Nature Communications study

https://ymaho.com/antidepressant-mianserin-extends-life-nature-communications-study

Nature Communications study: old antidepressant mianserin restores calcium homeostasis, extends mouse lifespan by 30%, and fights aging. Learn the mechanism and repositioning prospects.

STimage AI tool Nature Communications: search for hidden cancer

https://ymaho.com/stimage-ai-tool-nature-communications-search-for-hidden-cancer

Scientists at QIMR Berghofer developed STimage — AI for tissue analysis and detection of hidden cancer markers. Learn how spatial transcriptomics is changing diagnostics.

Mianserin: treatment of progeria increased lifespan

https://ymaho.com/mianserin-treatment-of-progeria-increased-lifespan

Nature Communications study: antidepressant mianserin restores calcium homeostasis and prolongs life in mice with progeria and aging mice. Learn about the S100A6 and cGAS-STING mechanism.

Artificial neurons: signals identical to biological ones

https://ymaho.com/artificial-neurons-signals-identical-to-biological-ones

Breakthrough at Northwestern University: printed neurons communicate with living brain in its language. Learn how this will change neuroprosthetics and AI. Read the analysis.

AAV9 gene therapy for SMA: long-term efficacy study

https://ymaho.com/aav9-gene-therapy-for-sma-long-term-efficacy-study

A long-term study in Nature Communications confirmed the efficacy of optimized AAV9 gene therapy for spinal muscular atrophy. Learn about safety and treatment prospects.

Trending Now